The Extraordinary General Meeting in
Resolution on issue of new shares
The General Meeting resolved to increase the Company's share capital by a maximum of
The new shares may, with deviation from the shareholders' preferential right, only be subscribed for by
Subscription must take place no later than
For more information, please contact:
President and Chief Executive Officer
ir@irras.com
About IRRAS
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in
IRRAS maintains its headquarters in
IRRAS is listed on Nasdaq Stockholm (ticker: IRRAS).
https://news.cision.com/irras/r/bulletin-from-the-extraordinary-general-meeting-in-irras-ab--publ--on-13-october-2023,c3853702
https://mb.cision.com/Public/16550/3853702/b71fdfe4e4edc162.pdf
(c) 2023 Cision. All rights reserved., source